- How will the ACA impact Medical Products?
The new Patient Protection and Affordable Care Act (ACA) is affecting health care providers plans for 2013 and medical marketers need to revise their product strategies.
- Know Your Opportunities
A detailed commercial opportunity assessment is often the best way to answer important questions before you approach the FDA or MDDD with your product.
- Don’t Stay Outside!
Overseas companies can access the large US market through distributors but it is vital to recognize three parameters and negotiate a win-win legal agreement.
- Don’t Go It Alone: Benefits of Partnering
Given the regulatory, investment and commercialization risks for US product launches, most medical device and biotech companies need to consider partnering options.
- Business Trends for 2012/2013
It will be a year of change in the US and EU as the FDA, the ACA, MDDD and the growth of new technology will combine with financial challenges to test development and sales plans.
- Pivot to Succeed
The importance of commercial assessment as a part of the innovation process is key along with the ability to quickly modify your plan.
- Treasure Chest or Trap? The U.S. Market for Foreign Life Science Companies
The reward in potential revenues in the US well outweigh the risks if an internationally-based company simply follows six important launch rules.
- Curing the “Plague”
Licensing your product to a global medical firm is a great opportunity for revenues but you will not get the proper attention if you join the ‘plague’ of over-eager submissions.
- Preventing Cold Feet and Bloody Noses
The US is the largest medical product market in the world but European firms need to consider four critical issues before they “leap into” North America.
- “Steroid Marketing”
Sales growth can occur from smart marketing if the targets are well researched and your promotional methods create a unique message…and you do not need a “steroid budget”.
- Gesundheitsmarkt USA (German)
An overview of the huge US medical device market and its opportunity for European firms based on a workshop given by TCG several years ago…and still true today.